Regulation
Abbott’s paravalvular leak treatment secures FDA approval
Abbott received FDA approval for the Amplatzer Paraclose Occluder, a device designed to treat paravalvular leaks—gaps that form around replacement heart valves. The device addresses a clinical need to reduce the requirement for revision surgery in patients with this complication.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network